Boryeong Openly Hires New Sales Employees in the First Half of This Year...Applications will be accepted by July 6th

Jun 26, 2025

Boryeong Openly Hires New Sales Employees in the First Half of This Year...Applications will be accepted by July 6th



Boryeong Co., Ltd. will open recruitment of new sales staff in the first half of this year.

Applications can be made through the Boryeong recruitment site by July 6, and the screening process will be in the order of ▲ document screening ▲ 1st interview ▲ 2nd interview ▲ announcement of successful applicants.

Qualification requirements are college graduates or higher, and those who are scheduled to graduate in August of this year can also apply. The major is irrelevant and favors local talent and those who can work in the local area. Boryeong has expanded its recruitment scale in line with its continued growth and business expansion, and plans to hire a total of double-digit personnel from across the country, including the Seoul metropolitan area, Gangwon, Chungcheong, Gyeongsang, and Jeolla.




The tasks in charge include specialty drug sales, management of local hospitals and clinics, and pharmaceutical-related seminars. Successful applicants will learn the entire necessary competencies, from basic drug knowledge to sales communication skills, through a five-week new entrance training course after joining the company.

Boryeong deleted most of the so-called 'spec' entries, such as language scores, overseas experiences, award-winning experiences, and volunteer activities in the first half of this year, and excluded the existing 'AI competency test'. Instead, the evaluation of self-introduction letters was greatly strengthened for evaluation centered on 'job suitability'.

In addition, in order to reduce the burden on applicants and select excellent local talents, the first interview will be conducted with 'Visiting Recruitment'. The first interview will be held in four areas, including Seoul, Chungcheong (Daejeon), Jeolla (Gwangju), and Gyeongsang (Busan).






This article was translated by Naver AI translator.